Drug Uptake and Modulation of Drug Resistance in Leishmania by an Aquaglyceroporin

This publication has 34 references indexed in Scilit:

• Thiol-induced reduction of antimony(V) into antimony(III): A comparative study with trypanothione, cysteinyl-glycine, cysteine and glutathione
  BioMetals, 2003
• Malaria: current status of control, diagnosis, treatment, and a proposed agenda for research and development
  The Lancet Infectious Diseases, 2002
• Visceral leishmaniasis caused by Leishmania (Viannia) braziliensis in a patient infected with human immunodeficiency virus
  Revista do Instituto de Medicina Tropical de São Paulo, 2002
• Leishmaniasis
  American Journal of Clinical Dermatology, 2002
• Novel Intracellular SbV Reducing Activity Correlates with Antimony Susceptibility in Leishmania donovani
  Journal of Biological Chemistry, 2001
• Failure of Pentavalent Antimony in Visceral Leishmaniasis in India: Report from the Center of the Indian Epidemic
  Clinical Infectious Diseases, 2000
• Purification and Characterization of Acr2p, theSaccharomyces cerevisiae Arsenate Reductase
  Journal of Biological Chemistry, 2000
• Axenically Grown Amastigotes of Leishmania infantum Used as an In Vitro Model To Investigate the Pentavalent Antimony Mode of Action
  Antimicrobial Agents and Chemotherapy, 1998
• ABC transporters in Leishmania and their role in drug resistance
  Drug Resistance Updates, 1998
• Antimonite is accumulated by the glycerol facilitator GlpF in Escherichia coli
  Journal of Bacteriology, 1997